Tokyo, Japan

Shuko Okazaki


 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Sunto-gun, JP (2011)
  • Tokyo, JP (2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shuko Okazaki: Innovator in Pharmaceutical Chemistry

Introduction

Shuko Okazaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrimidodiazepinone compounds and derivatives. With a total of 2 patents, Okazaki continues to push the boundaries of medicinal chemistry.

Latest Patents

Okazaki's latest patents include a pyrimidodiazepinone compound and a pyrimidodiazepinone derivative. The pyrimidodiazepinone compound is represented by a general formula that includes various substituents, allowing for a range of pharmaceutical applications. The pyrimidodiazepinone derivative also features a complex structure, providing potential therapeutic benefits through its unique chemical properties.

Career Highlights

Shuko Okazaki is currently associated with Kyowa Hakko Kirin Co., Limited, where he applies his expertise in drug development. His work has been instrumental in advancing the understanding of pyrimidodiazepinone compounds, which are crucial in the development of new medications.

Collaborations

Okazaki has collaborated with notable colleagues such as Nobumasa Otsubo and Yukihito Tsukumo. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical chemistry.

Conclusion

Shuko Okazaki's contributions to the field of pharmaceutical chemistry are noteworthy, particularly through his innovative patents. His work continues to influence the development of new therapeutic compounds, showcasing the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…